Business Context and Reporting Period
This Form 8-K was filed by Astro-Med, Inc. on October 27, 2006. The report details a material definitive agreement approved by the Compensation Committee regarding executive compensation tied to the sale of the company's Braintree, Massachusetts facility and the subsequent relocation of operations.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figures disclosed relate to one-time cash bonuses approved for senior executives:
- Albert W. Ondis (CEO): $397,422
- Everett V. Pizzuti (President and COO): $162,578
- Joseph P. O'Connell (Treasurer and CFO): $20,000
- Total Bonuses Approved: $579,999
Material Changes
The primary material change reported is the authorization of the aforementioned cash bonuses. This action is directly linked to the successful consummation of the sale of the Braintree facility (previously disclosed on September 21, 2006) and the completion of the relocation of operations from that site.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies beyond the context of the completed facility sale and relocation.
Investor Verification Checklist
- Verify the final sale price and net proceeds from the Braintree facility transaction referenced in the September 21, 2006 filing.
- Confirm the impact of the $579,999 bonus payout on the company's current quarter cash flow and earnings.
- Review the status of the relocated operations to ensure no disruption to revenue generation.
- Check for any additional disclosures regarding the terms of the facility sale agreement.